News | Thrombectomy Devices | June 11, 2015

Aspire Thrombectomy Device Effective in Removing Clot

Patient presented with cold leg

Aspire, thrombectomy, C. Dorn Smith, aspirators, clot, cold leg, removal

Clot in femoral artery caused by atrial fibrillation


June 11, 2015 - C. Dorn Smith, M.D., vascular surgeon in Kingstree, South Carolina, was successful in using a new device to remove blood clots from a patient with a cold leg using the Aspire mechanical thrombectomy device.

The patient presented with a cold leg and in atrial fibrillation, and Smith performed an angiogram. The angiogram revealed a 30 mm occlusion in the common femoral artery. Patients with atrial fibrillation often produce a clot from the heart that then travels to other areas of the body. Smith made four passes with the Aspire mechanical thrombectomy device. The Aspire device removed the clot, which was evident on a completion angiogram.

"Patients presenting with a cold leg need treatment immediately," said Smith. "The Aspire device was simple to set up and effective in removing the clot. This is a valuable tool in our toolbox to treat cardiovascular disease."

The Aspire mechanical thrombectomy system allows clinicians to instantly start, stop, increase, decrease, pulse or maintain thrombectomy force during a procedure. Aspire mechanical aspirators also aspirate up to 280ml, almost 10 times more than basic syringe-based systems, without multiple messy and time-consuming catheter connections, disconnections, and re-connections to improve speed and performance.

The patented system is available by itself or in kits that include an over-the-wire or rapid exchange thrombectomy catheter. Aspire mechanical aspirators may also be connected to any thrombectomy catheter the clinician chooses.

For more information: www.controlmedtech.com


Related Content

News | Thrombectomy Devices

Nov. 5, 2024 —Penumbra, Inc. recently announced new data that demonstrate patients with intermediate-risk pulmonary ...

Home November 07, 2024
Home
News | Thrombectomy Devices

Sept. 24, 2024 — Thrombolytic Science, LLC (TSI) has announced that the U.S. Food and Drug Administration (FDA) has ...

Home September 24, 2024
Home
News | Thrombectomy Devices

Sept. 5, 2024 - Prolocor, Inc. and Slingshot Biosciences recently announced the publication in Bioanalysis of the ...

Home September 10, 2024
Home
News | Thrombectomy Devices

January 16, 2024 — Penumbra, Inc., a thrombectomy company, has recently secured CE Mark (Conformité Européenne) for its ...

Home January 16, 2024
Home
Feature | Thrombectomy Devices | By Global Market Insights

The global thrombectomy devices market is poised to experience substantial expansion, owing to the emergence of ...

Home June 27, 2022
Home
News | Thrombectomy Devices

January 10, 2022 – Akura Medical Inc., a Shifamed portfolio company, announced the closing of its $25 million Series A1 ...

Home January 10, 2022
Home
News | Thrombectomy Devices

November 12, 2021 — Penumbra Inc. announced that the CHEETAH clinical study of its Indigo System CAT RX Catheter ...

Home November 12, 2021
Home
News | Thrombectomy Devices

January 8, 2021 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Inari Medical Inc ...

Home January 08, 2021
Home
News | Thrombectomy Devices

September 25, 2020 — Philips Healthcare launched its QuickClear mechanical thrombectomy system. The compact, single-use ...

Home September 25, 2020
Home
Technology | Thrombectomy Devices

July 25, 2019 — Penumbra announced U.S. commercial availability of the Penumbra System’s most advanced technology, the ...

Home July 25, 2019
Home
Subscribe Now